Live Breaking News & Updates on Swanbridge Capital

Stay updated with breaking news from Swanbridge capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord Holland , Cedric Van Nevel , Maarten Ligtenberg , Rudi Beyaert , Allard Kaptein , Innovatiefonds Noord Holland , Shobhit Dhawan , Brabantse Ontwikkelings Maatschappij , Christina Takke , Dennis Riedl , Flanders Institute Of Biotechnology , Netherlands Cancer Institute , Brabant Development Agency , Ministry Of Economic Affairs , Flanders Future Tech Fund , Jjdc Inc , Inflammation Research , Loncode Institute , V Bio Ventures , Johnson Innovation , Curie Capital , Oncode Oncology Bridge Fund , Bio Ventures , Gram Drug Discovery , Immunogram Drug Discovery , Swanbridge Capital ,

Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital | More News

Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital | More News
pipelinereview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pipelinereview.com Daily Mail and Mail on Sunday newspapers.

Zuid Holland , Michel Briejer , Van Herk , Dharminder Chahal , Chris Bangma , Katrien Reynders Frederix , Zealand Pharma , Van Herk Groep , University Medical Center , Erasmus Medical Center , Additional Funding , Existing Shareholders , New Investor Thuja Capital , Netherlandsi October , Thuja Capital , Van Herk Ventures , Swanbridge Capital , Chimeric Antigen Receptor , Investment Manager , Supervisory Board , Erasmus University Medical Centre , Herk Ventures , Rotterdam Based Van Herk Groep ,

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center | Proteins and Peptides

Hits: 1900
- Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland
ROTTERDAM, The Netherlands I February 8, 2021 I Pan Cancer T B.V., a biotech spin-off from the Erasmus Medical Center founded by Prof. Dr. Reno Debets (CSO) and Dr. Dora Hammerl (VP R&D), announces the closing of a seed investment and start of operations. Together with Katrien Reynders-Frederix (CEO), the team is committed to the discovery and development of novel TCR therapies against solid tumors such as triple negative breast cancer, bladder cancer, lung cancer, and glioma. Seed investors are Swanbridge Capital and Van Herk Ventures, and the Company is further awarded a Health~Holland grant for a public-private-partnership with Erasmus Medical Center. ....

Zuid Holland , Thijs Spigt , Cillian King , Van Herk , Reno Debets , Katrien Reynders Frederix , Zealand Pharma , Van Herk Groep , Technology Transfer Office , Professor At Erasmus Medical Center , Health Holland , Erasmus Medical Center Rotterdam , Erasmus Medical Center , Company Pan Cancert Launched As , Onco Immunology Company Pan Cancert Launched , T Cell Receptor , Swanbridge Capital , Van Herk Ventures , Netherlandsi February , Dora Hammerl , Erasmus Medical , Chimeric Antigen Receptor , Erasmus Medical Centerrotterdam , Investment Manager , Swanbrigde Capital , Herk Ventures ,